Wound care billing
In most specialties a service is covered because it was reasonable and necessary for the patient in front of the clinician. In wound care, service after service is covered only on a condition about something else -- a procedure that preceded it, a therapy that was tried and failed, a wound classification that has to be established before the product touches it. A claim can therefore be clinically unimpeachable and still fall outside the benefit, and the record has to answer a question about the past.
- A surgical dressing is covered for a wound caused by, or treated by, a surgical procedure -- or after a debridement
- The debridement clause reaches any type of debridement, provided it was reasonable and necessary
- Electrical stimulation and electromagnetic therapy are non-covered as an initial treatment and when used unsupervised
- CMS defines the standard wound care that must be tried first, inside the coverage determination itself
This is an educational guide to how billing works for wound care — its workflow, coding, and payer considerations. It is general information, not a statement that US Medical Billing serves this specialty, and not billing, coding, or legal advice.
What makes wound care billing distinct
Start with the dressing, because it is the item a wound care practice handles most and the one whose coverage rule surprises people most. The Benefit Policy Manual limits surgical dressings to primary and secondary dressings required for the treatment of a wound caused by, or treated by, a surgical procedure performed by a physician or other health care professional. Then it adds the clause that does the real work: surgical dressings required after debridement of a wound are also covered, irrespective of the type of debridement, as long as the debridement was reasonable and necessary and was performed by someone acting within their legal authority. Between the two clauses, the benefit only reaches a dressing that follows something. A chronic wound that is cleansed, assessed and dressed, with no surgery and no debridement behind it, has no covered surgical dressing at all.
The same manual then splits the dressing two ways depending on who applied it. Where a physician, physician assistant, nurse practitioner, clinical nurse specialist or certified nurse midwife applies surgical dressings as part of a professional service billed to Medicare, the dressings are considered incident to that professional service -- there is no separate claim. Where they are not covered incident to a practitioner's service and the patient obtains them from a supplier on an order from a professional authorized to write one, they are covered separately under Part B. One product, two payment routes, decided by the circumstances of its application rather than by what it is. The manual also draws the boundary of the benefit tightly: elastic stockings, support hose, foot coverings, surgical leggings and pressure garments for the arms and hands are named as items not ordinarily covered as surgical dressings.
The conditional structure repeats, much more elaborately, for adjunctive therapy. Electrical stimulation and electromagnetic therapy for the treatment of wounds are covered only for chronic Stage III or Stage IV pressure ulcers, arterial ulcers, diabetic ulcers and venous stasis ulcers -- with chronic defined in the determination as an ulcer that has not healed within thirty days of occurrence -- and only after appropriate standard wound therapy has been tried for at least thirty days with no measurable signs of improved healing. They are nationally non-covered as an initial treatment modality, non-covered if measurable signs of healing are not demonstrated within any thirty-day period of treatment, and non-covered when used unsupervised.
The remarkable part of that determination is that CMS defines the prerequisite itself. Standard wound care, in the determination's own words, includes optimization of nutritional status, debridement by any means to remove devitalized tissue, maintenance of a clean, moist bed of granulation tissue with appropriate moist dressings, and necessary treatment to resolve any infection -- with additions that vary by wound type, including repositioning for pressure ulcers, off-loading of pressure and glucose control for diabetic ulcers, establishing adequate circulation for arterial ulcers, and compression for venous ulcers. A national coverage determination is naming nursing care, nutrition and positioning as the condition on which a billable therapy depends, and the determination also defines what counts as evidence that it worked: a decrease in wound size by surface area or volume, in exudate, or in necrotic tissue. Measurement is not documentation supporting the claim; measurement is the coverage criterion.
The pattern holds for biologics too, and there it turns on classification rather than sequence. Autologous platelet-rich plasma is nationally covered for chronic non-healing diabetic wounds, for a defined duration, when prepared by devices whose cleared indications include management of exuding cutaneous wounds -- and nationally non-covered for acute surgical wounds where it is applied directly to the closed incision, and for dehiscent wounds. Coverage beyond the national duration falls to the contractor. The same product, prepared the same way by the same clinician, is inside the benefit or outside it according to which wound it is put on.
How wound care billing flows
Every stage here answers a question about the wound's history before it answers one about today's encounter.
Classifying the wound, and dating it
Whether a wound is acute or chronic, its type, and how long it has been present are coverage facts rather than clinical background. Several determinations define chronic by elapsed time since occurrence, so the date of onset belongs in the record from the first visit.
Common operational challenges
The friction is between a clinical record written to describe healing and a benefit written to require evidence of its absence.
A supply whose coverage depends on a procedure
Dressings are consumed continuously and the procedure that makes them covered is intermittent. Keeping the link between the two visible on a claim, weeks after the debridement, is a records problem rather than a coding one.
Documenting failure precisely
The coverage criteria for adjunctive therapy require showing that standard wound care was delivered and did not produce measurable improvement. A note that emphasizes the care given, without the measurements that show it did not work, satisfies neither half.
Measurements taken inconsistently
Surface area and depth drive both code selection and the coverage criteria, and they must be comparable across visits and across clinicians. A change in measuring technique reads as clinical change that did not happen.
Products that change status with the wound
The same biologic or dressing can be covered on one wound and non-covered on another in the same patient. Product selection is therefore a benefit decision made at the bedside, where the coverage rule is least likely to be at hand.
Documentation and coding considerations
The notes below describe coverage conditions and bundling rules from the Medicare manuals and coverage determinations; they do not reproduce any code descriptions.
What makes a surgical dressing covered
Coverage is limited to primary and secondary dressings required for treatment of a wound caused by, or treated by, a surgical procedure -- and to dressings required after debridement of a wound, irrespective of the type of debridement, where the debridement was reasonable and necessary and performed within the professional's legal authority. Dressings are covered for as long as they are medically necessary.
Which items are not surgical dressings
The manual distinguishes primary dressings applied directly to the wound from secondary materials that secure them, and names items that are not ordinarily covered in this benefit -- elastic stockings, support hose, foot coverings, leotards, knee supports, surgical leggings, gauntlets and pressure garments for the arms and hands.
Debridement that belongs to another procedure
The NCCI Policy Manual treats debridement as included where a definitive procedure requires access through diseased tissue, where non-viable tissue around a lesion or injury must be removed to complete a procedure, and where the site of a graft, skin substitute or tissue transfer is prepared. Reported separately in those cases it is unbundling.
Active wound care and surgical debridement of one wound
Active wound care management codes are not reported alongside surgical debridement codes for the same wound, and the selective and non-selective debridement codes are not reported together for the same wound either. Non-contact low-frequency ultrasound is likewise not separately reportable with other wound care or debridement services for that wound.
Measurement as a coverage criterion
The determination for electrical stimulation and electromagnetic therapy defines measurable signs of improved healing as a decrease in wound size by surface area or volume, a decrease in exudate, or a decrease in necrotic tissue, and requires the therapy to stop once the wound bed is fully epithelialized. Those measurements decide coverage, not merely support it.
Denial and rejection risks
Most of these are benefit denials rather than medical-necessity ones, which changes what an appeal has to contain.
Dressings with no qualifying procedure behind them
A dressing supplied for a wound that has had neither a surgical procedure nor a debridement is outside the benefit. The appeal has to establish the qualifying event, not the clinical need for the dressing.
Adjunctive therapy started too early
Electrical stimulation and electromagnetic therapy are nationally non-covered as an initial treatment modality. Beginning them before the required course of standard wound care has been tried and documented is a coverage failure that later documentation cannot repair.
Continuation without demonstrated healing
Continued treatment is not covered where measurable signs of healing have not been demonstrated within a thirty-day period of treatment. A course that continues on clinical judgment alone accrues non-covered visits quietly.
Unsupervised use billed as therapy
The determination states that unsupervised use of these therapies for wound therapy is not covered, as it has not been found medically reasonable and necessary. The rule is about how the therapy was delivered, not about whether it helped.
A biologic applied to the wrong class of wound
Autologous platelet-rich plasma applied directly to a closed acute surgical incision, or to a dehiscent wound, is nationally non-covered even where it is covered for the same patient's chronic diabetic ulcer. The wound's classification is the coverage fact.
Payer-process considerations
This service line sits under unusually dense written coverage policy, national and local at once.
National determinations that specify the care around them
The wound determinations do not only say what is covered; they define the standard wound care that must precede it, the wound classifications it applies to, and the evidence of improvement that must be shown. Reading the determination is reading the documentation standard.
Contractor discretion where the national rule stops
Coverage of autologous platelet-rich plasma beyond the nationally covered duration is left to the Medicare Administrative Contractors, and uses of electrical stimulation and electromagnetic therapy not otherwise specified remain at contractor discretion. The applicable local policy is the operative document past that boundary.
Two payment routes for one dressing
A dressing applied as part of a billed professional service is incident to it; a dressing obtained from a supplier on a professional's order is covered separately under Part B. Practices that both treat and supply are running two claim streams for the same product.
Advance notice where coverage is expected to end
Because so many of these services stop being covered on a condition rather than on a clinical judgment, the point at which a course leaves the benefit is often foreseeable. That makes it a conversation to have with the beneficiary in advance rather than a balance to explain afterwards.
Revenue-cycle checkpoints
Most of these are recorded at the bedside and used months later, which is why they are so often missing.
- Record wound type, date of occurrence and classification at the first encounter, because several determinations define chronic by elapsed time
- Measure surface area and depth consistently at baseline and at every reassessment, using a comparable technique
- Establish the qualifying surgical procedure or debridement before treating a dressing as a covered surgical dressing
- Decide whether a dressing is incident to a billed professional service or supplied on an order, and bill only one of the two
- Document the standard wound care trial by its named elements, and the measurements that show it did not produce improvement
- Keep debridement off the claim where it prepared a graft, a tissue transfer, or access through diseased tissue
- Do not report active wound care management and surgical debridement for the same wound
- Check a biologic or skin substitute against its own coverage rule and the wound's classification before it is applied
- Issue an advance beneficiary notice before a course continues past the point coverage criteria are met
Related & connected
Services, tools, background reading and definitions that connect to the wound care revenue-cycle steps above.
Related services
- Coding supportDebridement bundling, active wound care pairs, and the documentation each coverage rule asks for.
- Denial managementAnswering a benefit denial about the wound's history rather than a clinical one about its treatment.
- Patient billing & supportHandling the responsibility side of a course of care whose coverage ends on a condition.
Calculators & tools
- ABN issuance checklistTelling a beneficiary in advance that a continuing course is expected not to be covered.
- Modifier 25 and 59 documentation checklistCheck whether the record supports a distinct-service modifier before a debridement pair goes out.
- Professional claim release checklistWhat to confirm before a professional claim leaves, including the facts a coverage rule turns on.
From the Knowledge Base
- Payer medical policyHow written policy decides coverage, and why it is the first document to read on a wound denial.
- National and local coverage determinationsHow NCDs and LCDs work, and where a national rule hands the question to a contractor.
- Non-covered service denialWhat it means for a service to be outside a benefit rather than short of documentation.
- The Advance Beneficiary NoticeThe instrument that turns a foreseeable end of coverage into a planned patient charge.
Glossary
- National coverage determinationThe document that here defines the standard wound care a therapy depends on.
- Local coverage determinationA contractor's written policy, which governs where the national rule stops.
- Covered serviceThe category a dressing enters only because a procedure or debridement preceded it.
- Advance Beneficiary NoticeThe written notice that shifts responsibility before an expected non-covered service.
Frequently asked questions
When is a surgical dressing actually covered?
When something happened to the wound first. The Benefit Policy Manual limits surgical dressings to primary and secondary dressings required for the treatment of a wound caused by, or treated by, a surgical procedure performed by a physician or other health care professional -- and adds that dressings required after debridement of a wound are also covered, irrespective of the type of debridement, provided the debridement was reasonable and necessary and performed by a professional acting within their legal authority. Dressings are covered for as long as they are medically necessary. A wound that has had neither a surgical procedure nor a debridement has no covered surgical dressing, however appropriate the dressing is.
Who bills for the dressing -- the practice or a supplier?
It depends on how it reached the wound. Where a physician, physician assistant, nurse practitioner, clinical nurse specialist or certified nurse midwife applies surgical dressings as part of a professional service billed to Medicare, the manual treats the dressings as incident to that professional service. Where they are not covered incident to a practitioner's service and the patient obtains them from a supplier on an order from a professional authorized under state law to make one, they are covered separately under Part B. The same product therefore reaches Medicare through two different routes.
Why was electrical stimulation for a wound denied when the patient clearly needed it?
Most likely because of where it sat in the sequence. The national determination covers electrical stimulation and electromagnetic therapy only as adjunctive therapies, only for chronic Stage III or Stage IV pressure ulcers, arterial ulcers, diabetic ulcers and venous stasis ulcers, and only after appropriate standard wound therapy has been tried for at least thirty days with no measurable signs of improved healing. It states three national non-coverages: not as an initial treatment modality, not where measurable signs of healing have not been demonstrated within any thirty-day period of treatment, and not where use is unsupervised. Each is a condition about the course of care rather than about the patient's need.
What does CMS mean by standard wound care?
It says so in the determination, which is unusual. Standard wound care there includes optimization of nutritional status, debridement by any means to remove devitalized tissue, maintenance of a clean, moist bed of granulation tissue with appropriate moist dressings, and necessary treatment to resolve any infection that may be present -- plus measures specific to the wound type, including repositioning for pressure ulcers, off-loading of pressure and good glucose control for diabetic ulcers, establishment of adequate circulation for arterial ulcers, and use of a compression system for venous ulcers. Because those elements are the coverage condition for the therapy that follows, they belong in the record as delivered care.
Can the same biologic be covered on one wound and not another?
Yes, and the determination for blood-derived products says so directly. Autologous platelet-rich plasma is nationally covered for the treatment of chronic non-healing diabetic wounds, for a defined duration, when prepared by devices whose cleared indications include the management of exuding cutaneous wounds. It is nationally non-covered for acute surgical wounds where it is applied directly to the closed incision, and for dehiscent wounds -- and autologous platelet-derived growth factor for chronic non-healing cutaneous wounds is non-covered as well. Coverage past the national duration is left to the contractors, so the wound's classification and duration decide the answer before the product does.
Sources
Last reviewed August 1, 2026.
- Centers for Medicare & Medicaid Services (CMS)Medicare Benefit Policy Manual (Pub. 100-02), Chapter 15 §100 Surgical Dressings, Splints, Casts, and Other Devices -- coverage limited to dressings required for a wound caused by or treated by a surgical procedure; the separate clause covering dressings required after debridement irrespective of its type; the distinction between primary and secondary dressings and the items not ordinarily covered; and the split between dressings incident to a practitioner's professional service and dressings covered separately under Part B on a supplier order
- Centers for Medicare & Medicaid Services (CMS)Medicare National Coverage Determinations Manual (Pub. 100-03) §270.1 Electrical Stimulation and Electromagnetic Therapy for the Treatment of Wounds -- the covered ulcer types and the definition of a chronic ulcer; the requirement that standard wound therapy be tried first; CMS's own definition of standard wound care and of measurable signs of improved healing; the requirement that the therapy be performed by a physician, physical therapist or incident to a physician service; and the three national non-coverages including unsupervised use
- Centers for Medicare & Medicaid Services (CMS)Medicare National Coverage Determinations Manual (Pub. 100-03) §270.3 Blood-Derived Products for Chronic Non-Healing Wounds, and §270.5 Porcine Skin and Gradient Pressure Dressings -- national coverage of autologous platelet-rich plasma for chronic non-healing diabetic wounds with contractor discretion beyond the covered duration; the national non-coverages for closed acute surgical incisions and dehiscent wounds; and the covered uses of porcine skin and gradient pressure dressings
- Centers for Medicare & Medicaid Services (CMS)National Correct Coding Initiative Policy Manual, Chapters I, III and XI -- debridement included where a definitive procedure requires access through diseased tissue; debridement of non-viable tissue needed to complete a lesion removal, incision or repair; debridement included in graft, skin substitute and tissue transfer procedures; and the rules preventing active wound care management codes from being reported with surgical debridement for the same wound
Ready to improve your revenue cycle?
Tell us about your practice and we’ll tell you where we would start.